Farm To Pharm Trademark Details
Word Mark | Farm to Pharm |
---|---|
Status | Dead 602 — Abandoned-Failure to Respond or Late Response |
Current Owner
Serial Number | 77747865 |
---|---|
Status Date | Thursday, March 13, 2014 |
Filing Date | Thursday, March 13, 2014 |
Attorney | George A. Pelletier, Jr. |
Domestic Representative | George A. Pelletier, Jr. |
Correspondent
GEORGE A. PELLETIER, JR.
CANTOR COLBURN LLP
20 CHURCH ST
FL 22
HARTFORD, CT 06103-1253
CANTOR COLBURN LLP
20 CHURCH ST
FL 22
HARTFORD, CT 06103-1253
Case File Statements
Indication of Colors | Color is not claimed as a feature of the mark. |
---|---|
Goods & Services | Hair Care Products, Namely, Shampoo, Hair Shampoo Concentrate, Conditions, Conditioner Shampoo, Neutralizer Shampoo, Re-Hydrating Shampoo, Conditioner and Hair Dressing, Hair Color, Hair Dye, Hair Highlights, Hair Frost, Hair Bleach, Peroxide, Hair Rinse and Setting Preparation, Instant Hair Conditioner, Hair Spray, Hair Finisher, Hair Relaxer, Hair Straightening Preparation, anti-Frizz Preparation, Hair Permanent Waving and Curling Preparation, Preparation for Increasing Hair Body, Rinse for Controlling, Preventing and Treating Dandruff, Sun Lotion and Sun Screen Preparation for the Hair, Preparation for After Sun Care of the Hair, Hair Styling Gel, Hair Mask, Hair Wax, Mustache Wax, Hair Setting Lotion, Hair Moisturizing Lotion, Hair Oil, Shaving Soap, Shaving Cream, Shaving Gel, Shaving Balm, Electric Shaving Lotion, After Shave Lotion, Hair Affixing Tape and Strips, Spirit Gum, Hair Piece Remover, Hair Piece Cleaner, Permanent Wave Kits Containing Relaxer, Neutralizing Shampoo and Hair Setting Lotion and |
Goods & Services | Biofuels, Namely, Gaseous, Solid and Liquid Fuel Derived from Plant and Other Biomass Material |
Goods & Services | pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, autoimmune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, and tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; and nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; extended release formulations, compositions and agents for use in the manufacture of human and veterinary medicinal products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release pharmaceuticals for the treatment of angina and hypertension; rapidly dissolving matrix preparations for the delivery of medicinal active ingredients for the treatment of humans and for veterinary use botanical preparations and substances for the prevention, treatment and alleviation of stress; botanical preparations and substances for the prevention, treatment and alleviation of diabetes; botanical preparations and substances for the prevention, treatment and alleviation of hypertension; botanical preparations and substances for the prevention, treatment and alleviation of angina; botanical preparations and substances for the cessation of smoking; botanical preparations and substances for the prevention, treatment and alleviation of sexually transmitted diseases; botanical preparations and substances for the prevention, treatment and alleviation of herpes; botanical preparations and substances for the prevention, treatment and alleviation central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders and smoking habits or addictions; botanical preparations and substances for the prevention, treatment and alleviation of neurological disorders, diseases, conditions and ailments, namely, brain injury, spinal cord injury, seizure disorders, Alzheimer's, Huntington's disease, and cerebral palsy; botanical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorders, cognitive disorders, schizophrenia, and depression; botanical preparations and substances for the prevention, treatment and alleviation of depression; botanical based anti-depressants; botanical preparations and substances for the prevention, treatment and alleviation of sleep disorders; botanical preparations and substances for the prevention, treatment and alleviation of anxiety; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; botanical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; botanical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; botanical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; botanical preparations and substances, namely, fibrinolytic or thrombolytic agents; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; botanical preparations and substances for the prevention, treatment and alleviation of immunological disorders, diseases, conditions and ailments, namely, autoimmune diseases, immunological deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), immunological dysfunctions, hypersensitivity, allergies, tumors of the immunological organs; botanical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; botanical preparations and substances for the preventions treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; botanical preparations and substances for the prevention, treatment and alleviation of irritable bowel disorder, Crohn's disease and ulcerative colitis; botanical preparations and substances for the prevention, treatment and alleviation of migraines; botanical preparations and substances, namely, botanical skin care preparations for use in dermatology, namely, dermatitis, psoriasis and skin pigmentation diseases; botanical preparations and substances for use in oncology; botanical preparations and substances for use in ophthalmology; and botanical based nutritional supplements, namely, vitamins, minerals, glucosamine and chondroitin; botanical preparations and substance delivery platforms for controlling the solubility, compressibility and/or flowability of botanical preparations and substances; extended release formulations, compositions, and agents for use in the manufacture of human and veterinary botanical products for the treatment of circulatory, respiratory, endocrine, neurologic, cardio vascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic gastrointestinal, bone, sensory, viral, urinary, renal, infectious, metabolic or central nervous system diseases, illnesses, disorders or conditions; extended release formulations, compositions and agents for use in the manufacture of human and veterinary botanical products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release botanical preparations formulations, compositions and agents for use in the manufacture of human and veterinary botanical products for the treatment of infertility, diabetes, and/or insulin imbalances; oral extended release botanical preparations and substances for the treatment of angina and hypertension; rapidly dissolving matrix preparations for the delivery of botanical active ingredients for the treatment of humans and for veterinary use biosensors for the identification and determination of concentration of substances and other parameters of biological interest; cosmeceutical products, namely, general and advanced hair care, cosmetic, tooth and mouth care, body care, anti-aging and anti-oxidant product lines that have medicinal or drug-like benefits; medical devices, namely, medical instruments for human and veterinary use |
Goods & Services | Drug Delivery Platforms for Controlling the Solubility, Compressibility and/or Flowability of Drugs; Extended Release Formulations, Compositions and Agents for Use in the Manufacture of Human and Veterinary Medicinal Products for the Treatment of Circulatory, Respiratory, Endocrine, Neurologic, Cardiovascular, Alimentary, Oncologic, Auto-Immune or Immune-Related, Pulmonary, Musculoskeletal, Lymphatic, Gastrointestinal, Bone Sensory, Viral, Urinary, Renal, Infectious, Metabolic or Central Nervous System Diseases, Illnesses, Disorders or Conditions; Implantable and Extra-Corporeal Medical Devices for Human and Veterinary Non-Invasive or Surgical Repair, Fixation, Support, Immobilization or Stabilization of Trauma, Fractures, Disease, Disorders, Conditions and Ailments; Prostheses for Human and Veterinary Use |
Goods & Services | Paper Towels, Facial Tissues; Printed Matter, Namely, Product Monographs, Training Materials, Conference Programs, Newsletters, Brochures, Posters, Banners, and Reports, All Relating to the Fields of Pharmaceuticals, Botanical Products, Biosensors, Advanced Biofuels, Cosmeceutical Products, Body Care, Hair Care, Cosmetics, Tooth and Mouth Care Products and Medical Services; Registration, Manufacture, and Sales of General Product Lines and Advanced Pharmaceutical Products in the Field of Pharmaceuticals to the Order and Specification of Others; Research and Development in the Field of Pharmaceuticals; Formulation Development, Clinical Evaluation and Testing, Regulatory Registration and Joint Venture/Licensing of Pharmaceutical Compounds; Registration, Manufacture, and Sales of General Product Lines and Advanced Botanical Products in the Field of Botanical Products to the Order and Specification of Others; Research and Development in the Field of Botanical Products; Formulation Development |
Goods & Services | Registration, Manufacture, and Sales of General Product Lines and Advanced Biosensors in the Field of Biosensors to the Order and Specification of Others |
Goods & Services | Research and Development in the Field of Biosensors; Research and Development in the Field of Biofuels |
Goods & Services | Clinical Evaluation and Testing, Regulatory Registration and Joint Venture/Licensing of Botanical Products; Formulation Development, Clinical Evaluation and Testing, Regulatory Registration and Joint Venture/Licensing of Biosensors; Registration, Manufacture, and Sales of General Product Lines and Advanced Biofuels in the Field of Biofuels to the Order and Specification of Others; Formulation Development, Clinical Evaluation and Testing, Regulatory Registration and Joint Venture/Licensing of Biofuels; Registration, Manufacture and Sales of General Product Lines and Advanced Cosmeceutical Products in the Field of Cosmeceutical Products to the Order and Specification of Others; Research and Development in the Field of Cosmeceutical Products; Formulation Development, Clinical Evaluation and Testing, Regulatory Registration and Joint Venture/Licensing of Cosmeceutical Products; Registration, Manufacture and Sales of General Product Lines and Advanced Hair Care, Cosmetic, Tooth and Mouth Care and Body Care Product |
Pseudo Mark | Farm to Pharmaceutical |
Classifications
International Class Codes |
003
|
---|---|
U.S. Class Codes | 001, 004, 006, 050, 051, 052 |
Status | 6 — Active |
Status Date | Saturday, March 13, 2010 |
Primary Code | 003 |
International Class Codes |
004
|
---|---|
U.S. Class Codes | 001, 006, 015 |
Status | 6 — Active |
Status Date | Saturday, March 13, 2010 |
Primary Code | 004 |
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Tuesday, June 2, 2009 |
Primary Code | 005 |
International Class Codes |
010
|
---|---|
U.S. Class Codes | 026, 039, 044 |
Status | 6 — Active |
Status Date | Saturday, March 13, 2010 |
Primary Code | 010 |
International Class Codes |
016
|
---|---|
U.S. Class Codes | 002, 005, 022, 023, 029, 037, 038, 050 |
Status | 6 — Active |
Status Date | Saturday, March 13, 2010 |
Primary Code | 016 |
International Class Codes |
040
|
---|---|
U.S. Class Codes | 100, 103, 106 |
Status | 6 — Active |
Status Date | Saturday, March 13, 2010 |
Primary Code | 040 |
International Class Codes |
042
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Saturday, March 13, 2010 |
Primary Code | 042 |
International Class Codes |
044
|
---|---|
U.S. Class Codes | 100, 101 |
Status | 6 — Active |
Status Date | Saturday, March 13, 2010 |
Primary Code | 044 |
Trademark Timeline
-
May 29 2009Trademark application filed with USPTO
-
Jun 02 2009New Application Office Supplied Data Entered In Tram
-
Jun 03 2009Notice of Pseudo Mark Mailed
-
Aug 28 2009Assigned To Examiner
-
Sep 04 2009Notification of Non-Final Action E-Mailed
-
Sep 04 2009Non-Final Action E-Mailed
-
Sep 04 2009Non-Final Action Written
-
Mar 01 2010Teas Response To Office Action Received
-
Mar 13 2010Teas/email Correspondence Entered
-
Mar 13 2010Correspondence Received In Law Office
-
Mar 13 2010Assigned To Lie
-
Apr 06 2010Notification of Non-Final Action E-Mailed
-
Apr 06 2010Non-Final Action E-Mailed
-
Apr 06 2010Non-Final Action Written
-
Oct 06 2010Correspondence Received In Law Office
-
Oct 06 2010Teas Response To Office Action Received
-
Oct 07 2010Teas/email Correspondence Entered
-
Oct 27 2010Notification of Letter of Suspension E-Mailed
-
Oct 27 2010Letter of Suspension E-Mailed
-
Oct 27 2010Suspension Letter Written
-
Apr 28 2011Lie Checked Susp - To Atty For Action
-
Apr 28 2011Assigned To Lie
-
May 20 2011Notification of Inquiry As To Suspension E-Mailed
-
May 20 2011Inquiry To Suspension E-Mailed
-
May 20 2011Suspension Inquiry Written
-
Nov 21 2011Teas Response To Suspension Inquiry Received
-
Dec 07 2011Teas/email Correspondence Entered
-
Dec 07 2011Correspondence Received In Law Office
-
Dec 27 2011Notification of Letter of Suspension E-Mailed
-
Dec 27 2011Letter of Suspension E-Mailed
-
Dec 27 2011Suspension Letter Written
-
Jun 01 2012Assigned To Examiner
-
Jun 29 2012Lie Checked Susp - To Atty For Action
-
Jul 10 2012Notification of Inquiry As To Suspension E-Mailed
-
Jul 10 2012Inquiry To Suspension E-Mailed
-
Jul 10 2012Suspension Inquiry Written
-
Jan 09 2013Attorney Revoked And/or Appointed
-
Jan 09 2013Teas Revoke/appoint Attorney Received
-
Jan 09 2013Teas Response To Suspension Inquiry Received
-
Jan 22 2013Teas/email Correspondence Entered
-
Jan 22 2013Correspondence Received In Law Office
-
Jan 22 2013Applicant/correspondence Changes (non-Responsive) Entered
-
Jan 28 2013Notification of Letter of Suspension E-Mailed
-
Jan 28 2013Letter of Suspension E-Mailed
-
Jan 28 2013Suspension Letter Written
-
Jul 30 2013Lie Checked Susp - To Atty For Action
-
Aug 02 2013Notification of Inquiry As To Suspension E-Mailed
-
Aug 02 2013Inquiry To Suspension E-Mailed
-
Aug 02 2013Suspension Inquiry Written
-
Mar 13 2014Abandonment Notice Mailed - Failure To Respond
-
Mar 13 2014Abandonment - Failure To Respond Or Late Response